Many years from now, you’re reclining in one of the many gray-blue armchairs that line the walls of a clinic. Your arm is propped up on a collapsible plastic armrest, and two thin tubes lead from your wrist to the slender white machine next to you, one tube delivering your blood to the machine’s mysterious…

We know you want to keep up with the relentless march of progress, but sometimes it’s just too relentless. So why not forget all those endlessly scrolling feeds, and instead join us for a bi-weekly concentrated dose of all the most exciting developments in the field of geroscience? Here’s what’s happened in the last two weeks:…

Biomarkers are a big deal in the clinical world: if as a doctor you’re able to take one simple measurement that allows you to look into a patient’s future, you’ve potentially elevated your practice of medicine from imprecise art to exact science. The better the biomarkers in your arsenal, the more information you have to…

“Aging” isn’t a disease as recognized by the FDA–not yet anyway. But then how will the companies trialing anti-aging drugs ever get regulatory approval? It’s simple: just choose a “primary indication” to test your drug with. Of course, that choice itself is rather difficult when you’re considering a geroprotector. Here’s how investors think about it…

Last Wednesday I attended the Buck Institute’s workshop on AI and Longevity, where speakers from several different organizations discussed how they were using machine learning to advance different aspects of medical discovery. Uses for AI in aging include creating new drugs, finding new uses for existing drugs, and discovering new biomarkers–all of which are important…

Can we “unlock a human’s inner salamander” with stem cell therapies? 3D-printed organs, uploaded brains, and disease-fighting nanobots: just a few of the tools Silicon Valley hopes to put in our anti-aging arsenal. Entrepreneur and biohacker Serge Faguet shares practical tips on what he sees as the six key areas for maximizing one’s own longevity…

Is a picture worth a thousand biomarkers? MouseAGE, the AI that wants to eyeball the age of rodents, thinks so. thinks so Dr. Craig Thomspon talks cancer metabolism, and fills us in on how certain nutrients may explain the connection between cancer and obesity. “The TAME Trial would cost 96% less than the cost to…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD